Evidence map›Paper›PMID 22421879›Full record

ReviewNature reviews. Microbiology2012

The rise of the Enterococcus: beyond vancomycin resistance.

Cesar A Arias, Barbara E Murray

Abstract readReview
In one paragraph

Review in Nature reviews. Microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 889 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
889citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

889 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Global trends in antimicrobial resistance ofFrontiers in pharmacology · 2025
    Pooled it
  3. Bacterial Infections in Patients With Severe Alcohol-Associated Hepatitis: Drivers of Organ Failure and Mortality.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Trial
  4. Antibiotic-associatedGut microbes · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. TransferableApplied and environmental microbiology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

829 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Cesar A AriasDepartment of Internal Medicine, Division of Infectious Diseases, Center for the Study of Emerging and Re-emerging Pathogens, Houston, Texas 77030, USA. cesar.arias@uth.tmc.edu
Barbara E Murray

Funding

ALTERNATIVE APPROACHES FOR E FAECALIS INFECTIONSR37AI047923 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MURRAY, BARBARA E · 2000 to 2009
$4.0M
Molecular Mechanisms Of Daptomycin Resistance In EnterococciR01AI093749 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2011 to 2015
$1.9M
Importance of adhesin-like proteins of Enteroccocus faeciumR01AI067861 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MURRAY, BARBARA E · 2006 to 2010
$1.8M
Enterococcus faecium virulence: A molecular and therapeutic approachR00AI072961 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2009 to 2010
$593k
NIAID NIH HHS R00 AI072961NIAID NIH HHS R00 AI72961NIAID NIH HHS R01 AI067861NIAID NIH HHS R01 AI093749NIAID NIH HHS R37 AI047923NIAID NIH HHS R37 AI47923
6 · The paper itself

Abstract

The genus Enterococcus includes some of the most important nosocomial multidrug-resistant organisms, and these pathogens usually affect patients who are debilitated by other, concurrent illnesses and undergoing prolonged hospitalization. This Review discusses the factors involved in the changing epidemiology of enterococcal infections, with an emphasis on Enterococcus faecium as an emergent and challenging nosocomial problem. The effects of antibiotics on the gut microbiota and on colonization with vancomycin-resistant enterococci are highlighted, including how enterococci benefit from the antibiotic-mediated eradication of gram-negative members of the gut microbiota. Analyses of enterococcal genomes indicate that there are certain genetic lineages, including an E. faecium clade of ancient origin, with the ability to succeed in the hospital environment, and the possible virulence determinants that are found in these genetic lineages are discussed. Finally, we review the most important mechanisms of resistance to the antibiotics that are used to treat vancomycin-resistant enterococci.

Indexed as

AnimalsAnti-Bacterial AgentsBacterial ProteinsCross InfectionDrug Resistance, Multiple, BacterialEnteritisEnterococcus faeciumGastrointestinal TractGram-Positive Bacterial InfectionsHumansMicrobial InteractionsVancomycinVancomycin ResistanceVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsVancomycinVirulence Factors

Identifiers

PMID22421879
PMCPMC3621121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.